TMC
LJPC

Trellus Management Company’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Trellus Management Company’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-26,845
Closed -$236K – 81
2019
Q3 		$236K Buy
26,845
+15,024
+127% +$142K 0.24% 57
2019
Q2 		$109K Sell
11,821
-15,000
-56% -$113K 0.15% 64
2019
Q1 		$172K Buy
+26,821
New +$175K 0.33% 52
2015
Q2 		– Sell
-12,252
Closed -$224K – 128
2015
Q1 		$224K Sell
12,252
-4,900
-29% -$99.3K 0.27% 79
2014
Q4 		$316K Sell
17,152
-25,648
-60% -$304K 0.46% 58
2014
Q3 		$411K Sell
42,800
-3,500
-8% -$34.8K 0.35% 71
2014
Q2 		$425K Hold
46,300
– – 0.36% 72
2014
Q1 		$500K Buy
+46,300
New +$454K 0.45% 60

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Trellus Management Company's LJPC Position: Q4 2019 in Review

Trellus Management Company sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2019, closing a stake of 26,845 shares — an estimated $236K sold.

Trellus Management Company first reported a position in LJPC in Q1 2014 and held it in 8 quarters. The position peaked at $500K in Q1 2014. 77 funds tracked by Wall St. Rank hold LJPC as of Q4 2019.

  • Trellus Management Company reported no remaining La Jolla Pharmaceutical Company position as of Q4 2019 after selling out during the quarter.
  • Trellus Management Company sold 26,845 La Jolla Pharmaceutical Company shares in Q4 2019, an estimated $236K.
  • Trellus Management Company first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 8 quarters.
  • Trellus Management Company's La Jolla Pharmaceutical Company position peaked at $500K in Q1 2014.
  • 77 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2019.

Based on Trellus Management Company's 13F filing for Q4 2019, filed 20 Feb 2020.